MARKET

AYTU

AYTU

Aytu Biopharma Inc
NASDAQ
1.205
-0.015
-1.24%
After Hours: 1.260 +0.055 +4.57% 19:22 03/14 EDT
OPEN
1.230
PREV CLOSE
1.220
HIGH
1.230
LOW
1.200
VOLUME
21.63K
TURNOVER
--
52 WEEK HIGH
3.448
52 WEEK LOW
1.200
MARKET CAP
7.43M
P/E (TTM)
-1.1069
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AYTU last week (0303-0307)?
Weekly Report · 5d ago
COO’s Bold Move: Major Stock Purchase in Aytu BioScience!
TipRanks · 03/04 02:06
Weekly Report: what happened at AYTU last week (0224-0228)?
Weekly Report · 03/03 12:33
Based on the provided financial report articles, the title of the article is: "AYTU 2024 Q2 10-Q Filing: Form 10-Q for the quarterly period ended June 30, 2024" This title indicates that the article is a quarterly report (Form 10-Q) filed by Aytu BioScience, Inc. (AYTU) with the Securities and Exchange Commission (SEC) for the period ended June 30, 2024.
Press release · 03/01 09:34
Weekly Report: what happened at AYTU last week (0217-0221)?
Weekly Report · 02/24 12:33
Weekly Report: what happened at AYTU last week (0210-0214)?
Weekly Report · 02/17 12:29
Aytu BioScience: Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
TipRanks · 02/14 12:46
Aytu BioScience Earnings Call: Growth Amid Challenges
TipRanks · 02/14 00:27
More
About AYTU
More
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Recently
Symbol
Price
%Change

Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.